0.00Open0.05Pre Close0 Volume1 Open Interest3.00Strike Price0.00Turnover651.27%IV3365.91%PremiumFeb 21, 2025Expiry Date0.00Intrinsic Value100Multiplier87DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.6860Delta1.2696Gamma1.76Leverage Ratio-0.0006Theta0.0000Rho1.21Eff Leverage0.0002Vega
Bright Green Stock Discussion
Bright Green Corporation, a key player in the cultivation and supply of plant-based materials, has announced a strategic partnership with Benuvia Pharmaceuticals. This partnership signifies a major step in the integration of advanced plant-based pharmaceuticals into mainstream medicinal applications. The collabo...
Bright Green Corporation (Nasdaq: BGXX), a company involved in the production, market, and distribution of Schedule I-V plant-based drugs, including opium and cannabis, recently made significant strides in securing financial resources to advance its commercialization efforts. The company has announced the acquisition of a $3.5 million funding commitment under an ex...
No comment yet